MSB 2.51% 97.0¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-1059

  1. 2,769 Posts.
    lightbulb Created with Sketch. 1882
    Our stock, who art dual listed, Meso be thy name;
    thy BLA come; FDA will be done - in Oz and the USA.
    Give us this day our daily posts.And forgive us our long term
    hold status as we forgive those who cast aspersions against us. And lead us not into CRL nor cap raise but deliver us righteous approval .
    In the name of the board, shareholders and anonymous posters.

    Amen


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.